Monocal Calcium and Fluoride Supplement Recalled for Excess Fluoride
Mericon Industries is recalling Monocal Calcium & Fluoride Supplement because it contains an excess amount of fluoride.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score involving low-risk contamination or labeling issues.
Plain-English summary
Mericon Industries, Inc. is recalling 158 bottles of Monocal, Calcium & Fluoride Supplement, 100 Tablets. The product was manufactured in Peoria, Illinois, and is identified by Lot 73007 and UPC 0394-0105-02.
The recall was initiated because the dietary supplement contains an excess amount of fluoride. The affected units were distributed in North Carolina, Massachusetts, New Jersey, Wisconsin, Iowa, and to one customer in England.
Consumers who have this product should stop using it and contact the recalling firm for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Monocal, Calcium & Fluoride Supplement, 100 Tablets; Mericon Industries, Inc., Peoria, Illinois 61615; UPC: 0394-0105-02
- Manufacturer
- Mericon Industries Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 158
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 73007
Distribution
Related recalls
Other drug recalls
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateAjanta Pharma Recalls Ranolazine Tablets for Dissolution Failure
FDA (Drugs) · 2026-10-07
Similar recalls
- ModerateAidapak Recalls Calcium and Cholecalciferol Tablets Due to Labeling Errors
FDA (Drugs) · 2014-01-29
- CriticalFDA Recalls Calcium Glucosate Injection Due to Microbial Contamination
FDA (Drugs) · 2014-11-05
- Moderate
- LowMutual Pharmaceutical Recalls FIBRICOR Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-15
- SeverePharmakon Recalls Magnesium Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2016-07-20
- ModerateAidapak Recalls Multivitamin Chew Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-22